Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.95 USD | -4.22% | 0.00% | -28.74% |
08/05 | Transcript : Relmada Therapeutics, Inc., Q1 2024 Earnings Call, May 08, 2024 | |
08/05 | Relmada Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-28.74% | 8.9Cr | |
+16.73% | 12TCr | |
+13.04% | 11TCr | |
-5.80% | 2.4TCr | |
+1.98% | 2.26TCr | |
-10.09% | 1.82TCr | |
-40.52% | 1.68TCr | |
-14.00% | 1.62TCr | |
+1.18% | 1.34TCr | |
+24.18% | 1.13TCr |
- Stock Market
- Equities
- RLMD Stock
- News Relmada Therapeutics, Inc.
- Insider Trends: Insider 90-Day Selling Trend Extended at Relmada Therapeutics